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Why was the cohort set up?
The Canadian Longitudinal Study on Aging (CLSA) was
established to understand and address the needs of an ag-
ing population.1–3 Overall aims are to examine aging as a
dynamic process; to investigate the inter-relationship
among intrinsic and extrinsic factors from mid-life to older
age; and to capture the transitions, trajectories and profiles
of aging.4 A central objective in creating the CLSA was to
provide national infrastructure and build capacity for
state-of-the-art, interdisciplinary, population-based re-
search and evidence-based decision-making.5,6
The CLSA was designed to be a national, longitudinal
research platform that includes participants from all 10
Canadian provinces, and collects comprehensive data and
biological samples that will support a wide variety of
aging-related research questions.3 The cohort of 51 338
participants, aged 45–85 years at enrolment, is composed
of two complementary cohorts that may be studied sepa-
rately or together: (1) the Tracking cohort of 21 241 par-
ticipants randomly selected from within all 10 provinces
who are interviewed by telephone, and (2) the
Comprehensive cohort of 30 097 participants randomly se-
lected from within 25–50 km of 11 data collection sites
(DCSs) (in seven provinces) who are interviewed in person,
take part in in-depth physical assessments at DCSs, and
provide blood and urine samples. To support research that
integrates the two cohorts, a common set of questionnaire
information is being collected for both the Tracking and
Comprehensive cohorts, and the same core data and data
collection are planned for each future follow-up for both
cohorts. All participants will be followed-up every 3 years
after baseline until 2033 or until death. Recruitment and
baseline data collection were completed in 2015, and the
first follow-up was completed in mid-2018. Figure 14
shows an overview of the CLSA design.
Who is in the cohort?
The CLSA cohort is a national stratified sample of 51 338
women and men aged 45–85 years at the time of recruit-
ment. The inclusion of study participants as young as
45 years of age was motivated by the desire to capture
mid-life experiences, since important changes known to in-
fluence outcomes later in life occur during this period.7,8
The lower age limit at the baseline also allowed inclusion
of a sample from the baby boom cohort (i.e. those born be-
tween 1946 and 1964) that will constitute a significant per-
centage of older adults in the coming years.9,10 The upper
age limit was set to keep the focus on adults who have
reached old age living in the community. One of the inter-
ests in studying the oldest age group prospectively is to ex-
amine transitions into the final years of life.
Participation in the CLSA cohort is voluntary and all
individuals provided written informed consent.3 The selec-
tion and recruitment process is detailed elsewhere,3,11 but
in brief, a random sample of eligible households was con-
tacted, and if an eligible individual in the household was
identified, they were asked to provide their information to
the CLSA in order to be contacted for recruitment. Those
who responded by providing their contact information
were considered pre-recruits. These pre-recruits were then
contacted, and those who underwent all required baseline
interviews and assessments and provided written informed
consent were enrolled into the cohort. The participation
rate into the CLSA was about 45% with an overall re-
sponse rate of 10%.
In the Tracking cohort, participants were recruited
across the 10 provinces, and all questionnaire measures are
collected by computer-assisted telephone interviews
(CATI) administered through CLSA CATI sites established
in four regions across Canada to accommodate different
time zones and language (English or French) requirements
for questionnaire administration.
In the Comprehensive cohort, recruits were drawn from
individuals living within 25–50 km (depending on the city
and accessibility) of one of eleven purpose-built DCSs lo-
cated in seven provinces. DCSs are located in small,
medium and large cities, and several include large rural
catchment areas. Comprehensive cohort participants pro-
vide data through in-person home interview [computer-as-
sisted personal interview (CAPI)], and additional
questionnaires, tests, physical measurements and biological
specimens (blood and urine) that are collected at the DCS.
To participate in the Comprehensive cohort, participants
had to complete an in-home interview and the visit to the
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DCS at baseline. However, the provision of the biological
specimens or their health card number for data linkage
was optional.
Sample weights and eligibility of the CLSA
sample
Three sampling frames were used for recruitment into the
CLSA cohort: (1) recruitment from a subset of participants
in the Statistics Canada’s Canadian Community Health
Survey-Healthy Aging (CCHS-HA); (2) recruitment from
the registries of provincial health care systems; and (3) re-
cruitment using Random Digit Dialing (RDD) of landline
telephones. Since people with less education and lower
socio-economic status are often under-represented in
population-based studies,12–14 efforts were made to over-
sample certain areas identified using census data to ensure
these groups are represented in the CLSA. Sampling
weights were calculated for the combined cohort, as well
as for the Tracking and Comprehensive cohorts.11
Since the CCHS-HA was a nationally representative
sample of Canadians >45 years of age with a response rate
of >80%, it was used as the first sampling frame for the se-
lection of the CLSA cohort and therefore, the same eligibil-
ity criteria were applied to all sampling frames to ensure
consistency.15 Similar to CCHS-HA, the CLSA excludes
residents of the Canadian territories and some remote
regions, persons on Federal First Nations reserves and
other provincial First Nations settlements, full-time mem-
bers of the Canadian Armed Forces, and institutionalized
persons (including long-term care). In addition to these ex-
clusion criteria, participants had to be able to complete the
interviews in English or French and be physically and cog-
nitively able to participate on their own (e.g. able to hear,
able to answer).3 Participants who become institutional-
ized after baseline will continue to be followed until study
completion, death or loss to follow-up.
Sample size and power of the cohort
Given the diversity of goals for the research platform and
the statistical models used for these effects and estimates,
as well as those of future (and as yet unknown) research
questions, it was difficult to provide globally meaningful
effect sizes for sample-size calculations. Consequently, one
strategy used to determine CLSA sample size was to carry
out simulations based on projected evolutions of the cohort
experience over time, similar to a strategy used by the UK
Biobank.16
For these simulations, the prevalence of selected expo-
sures and the incidence of selected outcomes, such as par-
ticular chronic diseases, over the period of follow-up
were used as a guide to assess the adequacy of the pro-
posed sample size. First, the expected number of cases of
an outcome was simulated for each 3-year wave of the
CLSA based on sex- and age-specific incidence rates and
taking into account the aging of the cohort over time.
The simulations also accounted for mortality (based on
age- and sex-specific annual mortality rates from
Statistics Canada) and attrition due to loss to follow-up
[estimated at 0.5% per year based on the attrition rates
for the National Population Health Survey (1994–95 to
2000–01)].17,18 For example, for a condition with a high
annual incidence rate, such as hypertension (sex- and
age-specific incidence rates ranging from 31 to 43 cases/
1000 persons per year19), we would expect almost 1516
cases from a cohort of 20 000 people and 2273 cases
from a cohort of 30 000 people (at the end of baseline
data collection).
We also investigated the adequacy of the power profiles
for two types of outcomes: hazard ratios (for incidence
studies) and odds ratios (for nested case-control studies)
using an iterative simulation-based approach. Because the
Comprehensive cohort includes physical measures and bio-
logical specimens that may be relevant to many analyses,
we wanted to examine the power using just this cohort as
well as the full CLSA sample. Simulations were undertaken
to determine the minimum detectable hazard ratio
(MDHR) for the Comprehensive cohort (n¼ 30 000) and
the minimal detectable odds ratio (MDOR) for the com-
bined cohort (n¼ 50 000). The results of these simulations
demonstrate the robustness of the CLSA data to power a
wide variety of associations.17
Generalizability
Selected weighted demographic and social characteristics
of CLSA participants at baseline were compared with those
of the CCHS-HA and Statistics Canada Census 2011 (see
Table 1). These comparisons suggest that the weighted
Figure 1. CLSA data collection timeline.
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CLSA data are generalizable to the comparable Canadian
population on many key variables. As discussed above, the
CCHS-HA (2008–09) was an initial source of participants
for the CLSA Tracking cohort, with a subset of CCHS-HA
participants (56%) agreeing to be contacted by the CLSA
for possible recruitment.18,20 Approximately 20% of
CCHS-HA participants were also CLSA participants. We
conducted a sensitivity analysis by removing participants
that overlapped between CCHS-HA and CLSA, and the
results, with and without overlap, were not significantly
different (data not shown). Therefore, we present only the
comparison with the full CCHS-HA. It is important to
note that the results presented in Table 1 are based on sam-
pling inflation weights, and three distinct inflation sam-
pling weights were used to calculate descriptive results for
the Tracking, Comprehensive and overall cohorts
respectively.
Though generalizable to the Canadian population on
many important variables, some differences exist be-
tween the CLSA participants’ characteristics and CCHS-
HA participants (Table 1). The CLSA Comprehensive
cohort, in particular, are more educated, have higher
household income, have higher percentages of partici-
pants who are Canadian born and rate their general
health as very good.
By design, the Comprehensive cohort was recruited
from an area 25–50 km from a DCS and included small ur-
ban areas with rural populations, medium size urban areas
and large cities respectively. The weighted data for the
Comprehensive cohort alone, thus, reflects only these
regions and not the 10 provinces of Canada. Participation
in the Comprehensive cohort required a commitment to a
significant amount of time and effort to provide data.
These factors, along with the voluntary nature of participa-
tion in the CLSA, may have contributed to the differences
between the Comprehensive cohort, CCHS-HA and
Census data. The Tracking Cohort, especially with its links
to the CCHS-HA, was more similar to the CCHS-HA and
Census 2011.
Retention and accommodation strategies
In longitudinal studies, one of the main challenges is par-
ticipant engagement and retention.12,21 Barriers to partic-
ipant retention include: (1) participants moving from
their enrollment location; (2) participants developing
health-related barriers; (3) participants experiencing cog-
nitive decline; (4) participants entering long-term care;
and (5) participants withdrawing due to study fatigue or
associated reasons. In response to these barriers, CLSA
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Participant moves
Every attempt is made to continue to follow each partici-
pant over time as they change geographic locations. For the
Tracking cohort, this requires being able to continue to ad-
minister questionnaires by phone. For the Comprehensive
cohort, those who move into an area covered by another
DCS are re-assigned to the new DCS and undergo follow-up
as usual. If the participant has moved out of range of all
eleven DCSs, then we complete the data collection using a
telephone-based survey (called the DCS by phone). Since the
placement of DCSs covers many of the Canadian urban
population areas, we expected to be able to re-assign many
participants to a new DCS.
Participant develops health-related barriers
At the time of data collection, participants experiencing
hearing impairment, speech/language problems or vision
loss are offered accommodations, as required, in the inter-
view. Procedures and processes have been developed to
identify the appropriate accommodations, such as involv-
ing a helper (e.g. allowing a spouse to be present during
survey questions if they can assist in enunciating or com-
municating for a participant with hearing loss) or declining
a test for specific measures (e.g. physical function measures
when a participant cannot safely stand). Under exceptional
circumstances, modified interviews have been developed to
facilitate participation. A ‘DCS at home’ interview replaces
a DCS visit. This is meant to be used when a participant is
physically unable to attend a DCS location. This accom-
modation contains as much content from a regular DCS
visit as is possible. An ‘in-home by phone’ and ‘DCS by
phone’ interview collects only the questionnaire content
via telephone interview. These interviews are meant to ac-
commodate participants where an in-home or DCS visit is
not feasible. The proportion of participants who required
accommodations at follow-up was small.
Participant develops cognitive decline
One of the potential barriers to continued participation is
decline in cognitive abilities. Individuals at highest risk of
cognitive decline are those 70 years of age, which allows
us to identify those participants who may need a proxy de-
cision maker and/or proxy information provider.
Participants who were 70 years of age at baseline, and
participants who turn 70 at each subsequent wave, are
asked to indicate how they would like to participate in the
CLSA in the future should they become unable to provide
their own responses. If they indicate that they would like
to continue participating in the CLSA, they are asked to
provide consent for the CLSA to contact an identified
proxy to assist in providing responses should the need arise
in the future. In such cases, the contact information of a
proxy decision maker and proxy information provider, of-
ten the same person, is recorded.
Participant enters long-term care
When a CLSA participant moves into an institutional long-
term care setting or nursing home, we continue to attempt
to follow them using the accommodation strategies for
moving, for health-related barriers or for cognitive decline,
as appropriate. Participants who enter into assisted-living
facilities and supported senior’s housing continue to be
considered community living.
Participant withdraws
Due to the longitudinal design of the CLSA, great effort has
been made to continually engage participants in order to
keep them motivated to continue in the study. Outreach us-
ing various media, including direct mail, newsletters, sur-
veys, maintaining contact publications, social media posts
and participant engagement events, are being managed by
the CLSA Communications team and executed in partner-
ship with the CLSA Participant Management Team, Local
Site Principal Investigators and DCS staff members.
Retention rate and mortality rate
By the end of the first follow-up, 4.3% of participants had
withdrawn from active data collection; however 60.8% of
those withdrawn consented to continue passive data collec-
tion through data linkage. Participants who withdrew
tended to be older, were more often female, had lower lev-
els of income and education and worse self-rated general
health. An additional 2.7% of participants died since their
baseline assessment. This includes 4.1% in the Tracking
cohort and 1.8% in the Comprehensive cohort.
Decedent questionnaire
When possible, a decedent questionnaire is administered to
a close relative or friend after a participant dies. The CLSA
decedent questionnaire is designed to elicit information on
the date and cause of death, the trajectory of functional de-
cline, residential transitions and health care utilization for
the 3 months prior to death. Information is also sought on
the decedent questionnaire respondent’s perception of the
quality of dying and death of the deceased participant.
What has been measured?
The CLSA was designed, in collaboration with expert
working groups, to help understand the contributions of
biological, clinical, health outcomes, healthcare services,
lifestyle and behaviour, psychological and social measures
in adult development and aging.3,4 Several multidisciplinary
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issues critical to the understanding of the aging process were
considered, focusing on questions that could only be an-
swered with a longitudinal design.4,14,17,22 Feasibility and
practicality were assessed when considering measures. This
included consideration of administration time, psychometric
properties, relevance across age groups, unique resources, or
equipment required and availability of tools in English and
in French. All measures are referenced on the CLSA website
(https://datapreview.clsa-elcv.ca/). Table 2 summarizes the
domains and measures collected in the CLSA.
Questionnaires
There is a core set of questionnaire-based measures that
are common across the Tracking cohort and the
Comprehensive cohort.20,23 These measures cover an ex-
tensive set of domains including social and demographic
measures, health status and functioning measures, psycho-
logical measures, lifestyle and behavioural measures and
health care utilization. We use validated measures where
available in French or English or adopt established ques-
tionnaires from other national surveys such as Statistics
Canada’s Canadian Community Health Survey (CCHS).
Cognition
A number of cognitive measures to address memory and
executive function are administered to all CLSA partic-
ipants;24,25 these include the Rey Auditory Verbal
Learning Test – Trial 1 and five-minute delayed recall, the
Animal Fluency Test and the Mental Alternation Test.
Cognitive measures that are additionally administered to
the Comprehensive cohort participants are, the Controlled
Oral Word Association Test, Victoria Stroop Test,
Prospective Memory Test and Choice Reaction Time.
Medications
Medication and prescription drug use are part of the ques-
tionnaires for all participants, and information that is
more detailed is collected from Comprehensive cohort par-
ticipants, including an in-person review of medications
during the in-home visit and an in-depth ‘Disease
Symptom Questionnaire’ during the DCS visit.
Physical measures
Physical assessments are conducted only for the
Comprehensive cohort, as a part of the DCS visit. They in-
clude anthropometric measures, as well as assessments for
physical function, vision and hearing. In addition, partici-
pants undergo an electrocardiogram, spirometry lung-
function testing, an assessment of carotid intima-media
thickness using ultrasound and a dual-energy X-ray ab-
sorptiometry (DXA) scan for hip, spine, and whole body
bone density and body composition (bone, lean tissue and
fat tissue mass) measurements. By design many of the phys-
ical measures deemed important for in-person assessment,
including vision, hearing and physical functioning, are also
collected via self-report in the questionnaires.
Biological specimens
Of the 30 097 participants in the baseline Comprehensive
cohort, 27 170 (90.3%) and 28 783 (95.6%) provided
blood and urine samples respectively. Approximately
60 mL of non-fasting blood is collected into six tube types
to produce ten fraction types including serum, four types
of plasma (citrate, platelet poor citrate, heparin and
ethylenediaminetetraacetic acid (EDTA)), buffy coat, two
types of peripheral blood mononuclear cells (with and
without cell preservative), and three types of whole blood
(acid citrate dextrose, EDTA) including dried blood spots
(baseline only). Biospecimen collection and processing
takes place in the purpose-built laboratory at each DCS.
Blood samples are processed within 2 h of collection and
up to 5 h for urine from collection for a total of 42 0.5-mL
aliquots. Biospecimens are temporarily stored at 80C be-
fore shipping weekly in cryoshippers to the CLSA
Biorepository and Bioanalysis Centre (BBC) for long-term
storage in cryofreezers (190C). The core set of bio-
markers that have been analysed to date are described in
Table 3.
Data linkage
At the time of recruitment, participants were asked to pro-
vide their health insurance number if they consented to
linkage of their CLSA data to their records in existing
health care administrative databases. The purpose of these
potential linkages is to collect further information on medi-
cation use, health service utilization and hospital and phy-
sician visits, as well as to ascertain deaths and causes of
death. About 90% of participants provided CLSA with
their health insurance number.
Key findings of CLSA research
Table 1 provides an overview of socio-demographic, life-
style and health status characteristics of the CLSA partici-
pants at baseline. Of the combined cohort, 75% were
married or living with a partner, 39% are retired, and
10% partially retired, 12% self-report fair or poor general
health, 5% self-report fair or poor self-rated mental health,
11% are current smokers and 75% are regular drinkers.
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Table 2. Summary of measures in the CLSA Research Platform
Baseline Follow-up 1








Social and demographic measures
Socio-demographic characteristics x x x x
Social networks and social support availability x x x x
Social participation x x x x
Social cohesion x x
Online social networking x x x x
Informal/formal care giving and care receiving x x x x
Transitions in work and retirement x x x x
Work limitations x x
Social inequality x x x x
Wealth/income x x x x
Home ownership x x x x
Built environments x x x x
Migration, mobility, transportation x x x x
Life space assessment No x No x
Education x x x x
Ethnicity, language, religion x x x x
Family and living arrangements x x x x
Paid and unpaid work x x x x
Veteran identifier x x No No
Gender identity No No x x
Health status
Activities of daily living x x x x
Instrumental activities of daily living x x x x
Pain x x x x
Sleep No x No x
Women’s health x x x x
Medications x x x x
Self-reported function x No x x
General health/healthy aging x x x x
Chronic conditions x x x x
Chronic disease symptoms No x No x
Injuries x x x x
Oral health x x x x
Self-reported height and weight x NA x NA
Self-reported vision and hearing x x x x
Falls x x x x
Falls related to consumer products x x No No
Physical measures
Weight and height No x No x
Hip and waist circumference No x No x
Pulse rate and blood pressure No x No x
Electrocardiogram No x No x
Lung function No x No x
Bone density (dual-energy X-ray absorptiometry) No x No x
Body composition (dual-energy X-ray absorptiometry) No x No x
Carotid intima-media thickness (cIMT) No x No x
Hearing No x No x
Timed 4-metre walk No x No x
Timed get up and go (TUG) No x No x
Standing balance No x No x
(continued)
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The CLSA Report on Health and Aging in Canada, Findings
from Baseline Data Collection 2010–2015, provides a de-
tailed description of the key finding of the CLSA.4
The goal of the CLSA is to facilitate important and im-
pactful research on health and aging, and to direct health evi-
dence and policy to improve the lives of aging Canadians.3
Baseline data are currently available for researchers and part-
ners through a formal data access request. Data from the first
follow-up was made available in Spring of 2019. Lay summa-
ries of all ongoing projects are available on the CLSA website
(available at https://www.clsa-elcv.ca/). Numerous studies
have already resulted in publications in a variety of areas, and
links to published works can be found on the CLSA website
(available at https://www.clsa-elcv.ca/).
What are the main strengths and
weaknesses?
The size, depth and breadth of data in the CLSA enable the
investigation of various understudied and novel areas that
Table 2. Continued
Baseline Follow-up 1








Chair rise: balance and coordination No x No x
Visual acuity No x No x
Tonometry No x No x
Retinal scan No x No x
Grip strength No x No x
Biological specimens
Blood No x No x
Urine No x No x
Cognition
Executive function x x x x
Memory x x x x
Reaction time No x No x
Prospective memory No x No x
Subjective cognitive decline/meta memory No No x x
Psychological function
Depression x x x x
Satisfaction with life x x x x
Personality traits No x No x
Posttraumatic stress x x No No
Psychological distress No x No x
Loneliness No No x x
Abuse and maltreatment x x
Childhood maltreatment and health across the lifespan No No x x
Elder abuse No No x x
Lifestyle/behaviour
Alcohol use x x x x
Tobacco use x x x x
Diet questionnaire No x No x
Nutritional risk x x x x
Dietary supplement use x x x x
Physical activity x x x x
Health care use
Health/social service provider visits x x x x
Unmet health care needs No No x x
Preventive health services No No x x
Data linkage x x x x
Decedent questionnaire No No x x
aFor a detailed explanation of specific measures and the tools and instruments used, please visit the CLSA website at www.clsa-elcv.ca
Source: Adapted from Raina P, Wolfson C, Kirkland S, Griffith L. The Canadian Longitudinal Study on Aging (CLSA) Report on Health and Aging in Canada:
Findings from Baseline Data Collection 2010–2015. Available from: https://www.CLSA-ELCV.ca (1 August 2018, date last accessed).
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are not currently addressed in ongoing or proposed studies
of aging in Canada or elsewhere.3 The CLSA includes par-
ticipants from age 45 at baseline, younger than those typi-
cally included in aging studies. This affords the advantage
of prospectively capturing middle life-course experiences
that may be associated with changes in health later in life.
At the other end of the age spectrum, the CLSA includes
participants at baseline aged 85 years. One of the inter-
ests in studying the oldest age group prospectively is to ex-
amine transitions into and in the final years of life.
The CLSA was designed as a platform to build capac-
ity for research on the many interrelated factors that af-
fect healthy aging over the life course.3 The longitudinal
design of the CLSA enables the interdisciplinary and
transdisciplinary study of health transitions and trajec-
tories.5 A primary goal of the CLSA is to support re-
search into the identification and understanding of the
complex interplay of modifiable risk factors, which will
lead to interventions that improve people’s health as
they age.6
Although sampling may be random, it is acknowledged
that due to self-selection cohort studies tend to recruit
healthier and wealthier participants. To be enrolled in the
CLSA, participants had to provide written consent. The
participants were required to complete French or English
language interviews by telephone and Comprehensive co-
hort participants were required to have an in-home visit
and a DCS visit. This may have resulted in a cohort that
under-represents people with lower levels of literacy in
French or English (e.g. recent migrants), with health prob-
lems, such as hearing problems, memory impairment and
mobility issues.4 This and the response rates at baseline
(comparable with other large cohort studies but still low)
limit the representativeness of the CLSA; however, key
CLSA measures for the entire cohort are comparable with
estimates generated from Canadian census data and other
nationally representative surveys like CCHS-HA with high
response rates (Table 1). Although our weighted preva-
lence estimates for chronic conditions are in line with these
nationally representative sources, caution is still warranted
especially when presenting prevalence estimates for sub-
groups (e.g. high income vs low income), but exposure–
disease and other complex relationships can be validly
tested using CLSA data.12,16
Table 3. List of biomarkers in the CLSA Research Platform
Category N Biomarkers
Hematologya 25 427 Erythrocytes Mean corpuscular volume (MCV)
Granulocytes Mean corpuscular hemoglobin) (MCH)
Hematocrit Mean corpuscular hemoglobin concentration (MCHC)
Hemoglobin Mean platelet volume (MPV)
Lymphocytes Red cell distribution width (RDW)
Platelets
Chemistrya 27 012 Albumin Alanine aminotransferase (ALT)
C-reactive protein (CRP) Hemoglobin A1c (n¼26 916)
Creatinine Thyroid stimulating hormone (TSH)
Cholesterol 25-Hydroxyvitamin Db
Ferritin Troponinc
Free T4 (Thyroxine) N-terminal pro b-type Natriuretic Peptide (NT ProBNP)c
Triglycerides HDL (High-density lipoprotein)
Non-HDL LDL (Low-density lipoprotein)
eGFR (estimated glomerular filtration rate)
Epigeneticsa 1488 DNA methylation
DNA extracted from PBMCs
850K Infinium Methylation EPIC BeadChip
(Ilumina)
Geneticsb,d 19 663 Genome-wide genotyping
DNA extracted from buffy coat (n¼26 855)
820K UK Biobank Axiom Array (Affymetrix)
aRepeated at each wave of the study.
bBaseline only.
cNew for follow-up.
dAll 26 855 will be completed by 2020.
Source: Adapted from Raina P, Wolfson C, Kirkland S, Griffith L. The Canadian Longitudinal Study on Aging (CLSA) Report on Health and Aging in Canada:
Findings from Baseline Data Collection 2010–2015. Available from: https://www.CLSA-ELCV.ca (1 August 2018, date last accessed).
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Is the CLSA data available for use?
A fundamental principle of the CLSA is to make data and
biospecimens available to the research community while
protecting the privacy and confidentiality of study partici-
pants. This principle is specified in the CLSA Data and
Biospecimen Access Policy and Guiding Principles. To
date, more than 133 applications to access the data have
been approved by the CLSA since 2016, more than 175
researchers and partners are using the CLSA platform and
more than 15 research papers have been published using
CLSA data. Special consideration is given to applications
supporting the training of highly qualified health researchers.
Currently, there are three deadlines each year for submis-
sion of applications to access CLSA data. The applications
are reviewed by the CLSA Data and Sample Access
Committee. The data access process is shown in Figure 2.4
Data access information, including an overview of the Data
Preview Portal, data release timelines, the data application
process and documents, application deadlines, the data and
biospecimen review process and data access FAQs are avail-
able on the CLSA website at www.clsa-elcv.ca26
Profile in a nutshell
The CLSA is one of the most comprehensive research
platforms for aging research
• The recruitment and baseline data collection on
51 338 men and women aged 45–85 occurred be-
tween 2011 and 2015.
• Continuous data collection occurs, producing a new
wave of follow-up data every 3 years.
• The CLSA collects information on the changing biologi-
cal, medical, psychological, social, lifestyle and economic
aspects of people’s lives. These factors are being studied
to understand how, individually and in combination,
they impact both the maintenance of health and the de-
velopment of disease and disability as people age.
• Data collected includes survey information on social
and demographic measures, health status, cognition
and psychological function on all participants, and
physical measures and imaging for over 30 000 of
the participants as part of the Comprehensive cohort.
• The data collection for the first follow-up wave was
completed in February 2019 and the second follow-
up wave began in April 2018.
• Information on the CLSA platform, and on how to
access the data, is available on the CLSA website at
www.clsa-elcv.ca
Funding
The Canadian Institutes of Health Research (CIHR) is the primary funder
of the CLSA. The infrastructure that supports the CLSA was funded by
the Canada Foundation for Innovation (CFI), 7 provincial governments
and 11 research institutions. Additional funding for the baseline and first
follow-up assessments was secured from the Public Health Agency of
Canada, Health Canada, the Ontario Ministry of Health and Long-term
Care and the Ontario Ministry of Transportation.
Acknowledgements
We would like to acknowledge the contributions to the paper of Drs
Carol Bassim, Ine Wauben and Istvan Molnar-Szakacs. P.R. holds a
Tier 1 Canada Research Chair in Geroscience and the Raymond and
Margaret Labarge Chair in Research and Knowledge Application
for Optimal Aging. L.E.G. is supported by CIHR New Investigator
Awards and by the McLaughlin Foundation Professorship in
Population and Public Health.
Conflict of interest: None declared.
References
1. Statistics Canada. An Aging Population. Ottawa: Statistics
Canada, 2010.
2. Cheal D. Aging and demographic change. Can Public Policy
2000;26:S109–122.
3. Raina PS, Wolfson C, Kirkland SA et al. The Canadian longitudi-
nal study on aging (CLSA). Can J Aging 2009;28:221–29.
4. Raina P, Wolfson C, Kirkland S, Griffith L. The Canadian
Longitudinal Study on Aging (CLSA) Report on Health and
Figure 2. CLSA data access timeline.






/ije/article-abstract/48/6/1752/5563992 by guest on 27 February 2020
Aging in Canada: Findings from Baseline Data Collection 2010–
2015. Available from: https://www.CLSA-ELCV.ca (1 August
2018, date last accessed).
5. Kirkland SA, Griffith LE, Menec V et al. Mining a unique cana-
dian resource: the canadian longitudinal study on aging. Can J
Aging 2015;34:366–77.
6. Orton L, Lloyd-Williams F, Taylor-Robinson D, O’Flaherty M,
Capewell S. The use of research evidence in public health deci-
sion making processes: systematic review. PLoS One 2011;6:
e21704.
7. MIDUS. Midlife in the United States (MIDUS) Study: Home,
2014. http://midus.wisc.edu/ (8 August 2019, date last
accessed).
8. HRS. The Health and Retirement Study: Home. http://hrsonline.
isr.umich.edu/index.html (8 August 2019, date last accessed).
9. Raina PS, Kirkland SA, Wolfson C et al. Accessing health care uti-
lization databases for health research: A Canadian Longitudinal
study on Aging feasibility study. Can J Aging 2009;28:287–94.
10. Wolfson C, Raina PS, Kirkland SA et al. The Canadian community
health survey as a potential recruitment vehicle for the Canadian
longitudinal study on aging. Can J Aging 2009;28:243–49.
11. Canadian Longitudinal Study of Aging (2017). Sampling and
Computation of Response Rates and Sample Weights for the
Tracking (Telephone Interview) Participants and Comprehensive
Participants. https://www.clsa-elcv.ca.
12. Fry A, Littlejohns TJ, Sudlow C et al. Comparison of sociodemo-
graphic and health-related characteristics of UK biobank partici-
pants with those of the general population. Am J Epidemiol
2017;186:1026–034.
13. Oremus M, Postuma R, Griffith L et al. Validating chronic dis-
ease ascertainment algorithms for use in the Canadian longitudi-
nal study on aging. Can J Aging 2013;32:232–39.
14. Raina PS, Wolfson C, Kirkland SA et al. Ascertainment of
chronic diseases in the Canadian longitudinal study on aging
(CLSA), systematic review. Can J Aging 2009;28:275–85.
15. Statistics Canada. Surveys and Statistical Programs—Canadian
Community Health Survey—Healthy Aging (CCHS), 2018.
http://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurvey
&SDDS=5146&lang=en&db=imdb&adm=8&dis=2.
16. Sudlow C, Gallacher J, Allen N et al. UK biobank: an open access
resource for identifying the causes of a wide range of complex
diseases of middle and old age. PLoS Med 2015;12:e1001779.
17. Ma J, Thabane L, Beyene J, Raina P. Power Analysis for
population-based longitudinal studies investigating gene-
environment interactions in chronic diseases: a simulation study.
PLoS One 2016;11:e0149940.
18. National Population Health Survey. National Population Health
Survey-Household Component, Cross-Sectional, 2003. https://
www12.statcan.gc.ca/census-recensement/2011/ref/92-135/sur
veys-enquetes/nationalhealth-nationalesante-eng.cfm (8 August
2019, date last accessed).
19. Robitaille C, Dai S, Waters C et al. Diagnosed hypertension in
Canada: incidence, prevalence and associated mortality. CMAJ
2012;184:E49–56.
20. Canadian Longitudinal Study on Aging. Canadian Longitudinal
Study on Aging: Data Support Documentation, 2018. https://
www.clsa-elcv.ca/.
21. Abshire M, Dinglas VD, Cajita MI, Eakin MN, Needham DM,
Himmelfarb CD. Participant retention practices in longitudinal
clinical research studies with high retention rates. BMC Med Res
Methodol 2017;17:30.
22. Balion CM, Raina P, Wolfson C et al. Feasibility of biological
specimen collection for the Canadian Longitudinal Study on
Aging (CLSA) Biorepository. Can J Aging 2009;28:251–59.
23. Canadian Longitudinal Study on Aging. Canadian Longitudinal
Study on Aging; Data Collection, 2018. https://www.clsa-elcv.ca.
24. Canadian Longitudinal Study on Aging. Canadian Longitudinal
Study on Aging: Comprehensive Baseline Cognition Measurements
Portal Dataset Overview. https://www.clsa-elcv.ca.
25. Canadian Longitudinal Study on Aging. Canadian Longitudinal
Study on Aging: Tracking Baseline Cognition Measurements.
https://www.clsa-elcv.ca.
26. Canadian Longitudinal Study on Aging. Canadian Longitudinal
Study on Aging: Data Access. https://www.clsa-elcv.ca.






/ije/article-abstract/48/6/1752/5563992 by guest on 27 February 2020
